Funding and Equity in University Startups: Basics on Investors – from SBIRs to StrategicsThe intended audience for this webinar is university startup founders, including future founders, and academic technology commercialization groups. Anurag Agarwal and Ajay Rayasam of OUP will review the Basics on Investors – from SBIRs to Strategics and cover the following areas: •…
In OUP’s third annual ‘Ask a VC’ webinar, our partner TTOs ask Managing Partners Marc Singer and Bill Harrington anything and everything as it pertains to venture capital operations, decision-making, and the current investing environment. The purpose of this webinar is to answer your questions on venture capital and startups. Query areas include: – What…
Equity compensation can be an opaque and awkward topic for first-time academic founders. Join us for a webinar that is an in-depth look at venture capital perspectives on the economics of university startup formation, particularly founders’ equity. OUP will review an analysis of the equity structures of over 90 startups combined with our collective insights…
Startup compensation is often an opaque and awkward topic for first-time academic founders. How much equity do I receive? My CEO? The PI(s)? Other co-founders? How will my choices affect future compensation?
Join OUP for a webinar on DEI initiatives for academics and tech transfer managers focused on entrepreneurship and commercialization. You will hear from five leaders in the field discussing programs and initiatives directed at promoting inclusion and dissolving the disparities for underrepresented populations in academic innovation.
In early 2022, OUP hosted a webinar on EIR/MIR Programs at Universities. Due to the overwhelming interest in the topic, we wanted to highlight two additional programs to offer perspectives from other universities. We spoke with Case Cortese, Director for Innovation, New Ventures & Entrepreneurship, to discuss Caltech’s entrepreneur-in-residence (EIR) program, and Mark VanderZyl, Associate…
For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.
Over the past year, tech transfer directors from Columbia, Duke, JHU, Penn, MIT, Stanford, and Yale worked with life science VCs from 5AM, Atlas, Polaris, OUP, RA Capital, and Venrock to create a common set of principles for university startup deal negotiations. These principles were captured in two documents: “Recommendations for Term Sheet Structuring”, covering equity, royalties, milestones, sublicensing, know-how royalties, diligence, and other recommendations for creating win-win outcomes; and “Recommendations for Process Improvements”, with recommendations for structuring the negotiation process itself to avoid unnecessary friction, gain buy-in early, and avoid overly long and painful negotiations.
This is part 1 of a 5-part webinar series called Startup Licensing 101: A Resource for Entrepreneurs Working with Companies Originated at Academic Institutions.
For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.
Corporate VCs have played a crucial role in financing life sciences companies for decades, but have you ever wondered what, if anything, makes them different from institutional venture capital funds? Join us for this webinar as we talk to a panel of investors at industry-leading CVC funds to learn more about their strategies, investment criteria, and how they measure success.